These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8059006

  • 1. Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats.
    Bryer-Ash M, Cheung A, Pederson RA.
    Regul Pept; 1994 May 05; 51(2):101-9. PubMed ID: 8059006
    [Abstract] [Full Text] [Related]

  • 2. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R.
    J Clin Invest; 1978 Jul 05; 62(1):152-61. PubMed ID: 659629
    [Abstract] [Full Text] [Related]

  • 3. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M, Schmidt WE, Ebert R, Strietzel J, Cantor P, Hoffmann G, Creutzfeldt W.
    J Clin Endocrinol Metab; 1989 Sep 05; 69(3):654-62. PubMed ID: 2668324
    [Abstract] [Full Text] [Related]

  • 4. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity.
    Heptulla RA, Tamborlane WV, Cavaghan M, Bronson M, Limb C, Ma YZ, Sherwin RS, Caprio S.
    Pediatr Res; 2000 May 05; 47(5):628-33. PubMed ID: 10813588
    [Abstract] [Full Text] [Related]

  • 5. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
    Meneilly GS, Ryan AS, Minaker KL, Elahi D.
    J Clin Endocrinol Metab; 1998 Aug 05; 83(8):2925-32. PubMed ID: 9709971
    [Abstract] [Full Text] [Related]

  • 6. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
    J Clin Endocrinol Metab; 1993 Apr 05; 76(4):912-7. PubMed ID: 8473405
    [Abstract] [Full Text] [Related]

  • 7. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA, Rizza RA, Nelson RL, Go VL, Gerich JE, Service FJ.
    J Clin Invest; 1980 May 05; 65(5):1119-25. PubMed ID: 6988457
    [Abstract] [Full Text] [Related]

  • 8. Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man.
    Füessl HS, Yiangou Y, Ghatei MA, Goebel FD, Bloom SR.
    Eur J Clin Invest; 1990 Oct 05; 20(5):525-9. PubMed ID: 2124984
    [Abstract] [Full Text] [Related]

  • 9. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ, Gallwitz B, Askenas M, Vollmer K, Deacon CF, Holst JJ, Schmidt WE, Nauck MA.
    Diabetologia; 2005 Sep 05; 48(9):1872-81. PubMed ID: 16010522
    [Abstract] [Full Text] [Related]

  • 10. Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus.
    Jones IR, Owens DR, Luzio S, Hayes TM.
    Horm Metab Res; 1989 Jan 05; 21(1):23-6. PubMed ID: 2647605
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide.
    Meneilly GS, Bryer-Ash M, Elahi D.
    Diabetes Care; 1993 Jan 05; 16(1):110-4. PubMed ID: 8422763
    [Abstract] [Full Text] [Related]

  • 14. [Effect of different dietary loads on glucose-dependent insulinotropic polypeptide in subjects with normal glucose tolerance].
    Chen Z, Yan L, Fu XY, Yang HZ, Kuang J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec 05; 31(12):2031-4. PubMed ID: 22200706
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man.
    Sarson DL, Wood SM, Holder D, Bloom SR.
    Diabetologia; 1982 Jan 05; 22(1):33-6. PubMed ID: 7037506
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of insulin secretory response to glucose-dependent insulinotropic polypeptide (GIP) by growth hormone in dogs.
    Pierluissi J, de Pierluissi R, de Martínez A.
    Acta Cient Venez; 2002 Jan 05; 53(1):29-35. PubMed ID: 12216497
    [Abstract] [Full Text] [Related]

  • 18. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.
    Chan CB, Pederson RA, Buchan AM, Tubesing KB, Brown JC.
    Diabetes; 1984 Jun 05; 33(6):536-42. PubMed ID: 6373459
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glucose-dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double-blind, placebo-controlled, crossover clinical trial.
    Heimburger SMN, Nielsen CN, Calanna S, Holst JJ, Vilsbøll T, Knop FK, Christensen MB.
    Diabetes Obes Metab; 2022 Jan 05; 24(1):142-147. PubMed ID: 34490741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.